Prof. Moji Adeyeye, Director General, National Agency for Food and Drug Administration and Control (NAFDAC) says no fewer than 35 containers of Tramadol have been seized at various ports in the country.
Adeyeye disclosed this while speaking with the News Agency of Nigeria (NAN) in Abuja on Sunday.
She said nine out of the seized containers of tramadol were released to NAFDAC by the Nigeria Custom Service (NCS), and had been destroyed by her agency.
“We are seriously working with the Customs on this and each time they seize any container, they usually invite us to come and see the containers with Tramadol.
“So far, 35 containers were seized and only nine of them have been handed over to NAFDAC which we have destroyed,” she said.
READ: Photo: Buhari departs Nigeria on two-day working visit to Morocco
She, however, decried the delay by the Customs in handing over the rest of the containers to her agency.
The NAFDAC boss stated that tramadol was a restricted drug but had been abused by Nigerian youths who use it without prescription.
According to Adeyeye, who is also a professor of pharmacology, the drug destroys children’s brain thereby threatening the future generation of the nation.
She lauded the present administration for placing an embargo on codeine, which she said, like tramadol, should only be given through prescription as done in advanced country.
The director general said the agency was more determined to stem the menace of illicit and fake drugs in the country.
What is Tramadol?
Tramadol, sold under the brand name Ultram among others, is an opioid pain medication used to treat moderate to moderately severe pain.
When taken by mouth in an immediate-release formulation, the onset of pain relief usually occurs within an hour. It is often combined with paracetamol (acetaminophen) as this is known to improve the efficacy of tramadol in relieving pain.
Common side effects include: constipation, itchiness and nausea. Serious side effects may include seizures, increased risk of serotonin syndrome, decreased alertness, and drug addiction.
A change in dosage may be recommended in those with kidney or liver problems.
It is not recommended in those who are at risk of suicide. While not recommended in women who are breastfeeding, those who take a single dose should not generally stop breastfeeding.
